You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 5, August 2, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Disease of Head & Neck
 •Bioterrorism
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic

Radiation Exposure and Thyroid Disease in Hiroshima and Nagasaki Atomic Bomb Survivors—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Völzke and Hoffmann raise questions about the cutoff point we used for determining TPOAb positivity in our participants. Setting of a defined cutoff point for thyroid autoantibody assay is a point of debate among clinical researchers. Our decision to use a 10-IU/mL value was based only in part on this being the value recommended by the manufacturer of the TPOAb enzyme-linked immunosorbent assay.1 More importantly, this cutoff value has been shown to be highly specific in terms of diagnosing autoimmune thyroid diseases (AITDs), with a specificity as high as 94.9%.2

Völzke and Hoffmann also comment on thyroid echogenicity as a diagnostic criterion for AITD. The accuracy of echogenicity assessment is partly operator dependent. Although every participant had undergone ultrasound examination, we felt it would be inappropriate to include thyroid echogenicity in the diagnostic criteria due to insufficient objectivity of the testing procedure. Studying the relationship between radiation . . . [Full Text of this Article]

Misa Imaizumi, MD
misaima@rerf.or.jp

Kiyoto Ashizawa, MD; Masazumi Akahoshi, MD
Department of Clinical Studies
Radiation Effects Research Foundation
Nakagawa, Japan


RELATED ARTICLES

Radiation Exposure and Thyroid Disease in Hiroshima and Nagasaki Atomic Bomb Survivors
Henry Völzke and Wolfgang Hoffmann
JAMA. 2006;296(5):512.
EXTRACT | FULL TEXT  

Radiation Dose-Response Relationships for Thyroid Nodules and Autoimmune Thyroid Diseases in Hiroshima and Nagasaki Atomic Bomb Survivors 55-58 Years After Radiation Exposure
Misa Imaizumi, Toshiro Usa, Tan Tominaga, Kazuo Neriishi, Masazumi Akahoshi, Eiji Nakashima, Kiyoto Ashizawa, Ayumi Hida, Midori Soda, Saeko Fujiwara, Michiko Yamada, Eri Ejima, Naokata Yokoyama, Masamichi Okubo, Keizo Sugino, Gen Suzuki, Renju Maeda, Shigenobu Nagataki, and Katsumi Eguchi
JAMA. 2006;295(9):1011-1022.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.